Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biodelivery Sci Intl (BDSI)

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 425,234
  • Shares Outstanding, K 89,523
  • Annual Sales, $ 55,640 K
  • Annual Income, $ -33,870 K
  • 60-Month Beta 0.33
  • Price/Sales 7.51
  • Price/Cash Flow N/A
  • Price/Book 6.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.07
  • Number of Estimates 5
  • High Estimate 0.01
  • Low Estimate -0.28
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.15 +15.66%
on 09/30/19
4.93 -2.74%
on 09/16/19
-0.01 (-0.21%)
since 09/13/19
3-Month
3.59 +33.70%
on 07/30/19
4.93 -2.74%
on 09/16/19
+0.73 (+17.94%)
since 07/12/19
52-Week
2.80 +71.43%
on 12/24/18
5.37 -10.67%
on 04/01/19
+1.32 (+37.93%)
since 10/12/18

Most Recent Stories

More News
Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases

Deep Clinical-Stage Pipeline Combined With World-Class Leadership Team

INNT : 1.11 (-1.50%)
BDSI : 4.80 (+1.05%)
BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA(R) and Symproic(R)

Major Pharmacy Benefit Manager (PBM) Improves Access for Both Products to Approximately 14 Million Lives

BDSI : 4.80 (+1.05%)
BioDelivery Sciences Announces Participation in Upcoming Investor Conferences

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced that Herm...

BDSI : 4.80 (+1.05%)
BioDelivery (BDSI) Up 8.9% Since Last Earnings Report: Can It Continue?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 4.80 (+1.05%)
BioDelivery Sciences Announces Upcoming Investor Conference Presentations

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced that Herm...

WFC : 49.27 (+0.12%)
BDSI : 4.80 (+1.05%)
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek(R) 2019 National Conference on Pain Management

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, today reported the acceptance of five scientific...

BDSI : 4.80 (+1.05%)
BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2

BioDelivery (BDSI) reports earnings against expectations of loss in Q2 and raises guidance for 2019.

CI : 151.58 (-0.54%)
BDSI : 4.80 (+1.05%)
ENDP : 3.36 (-9.31%)
TEVA : 6.73 (-2.46%)
BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations

BELBUCA(R) Net Sales Increased 147% versus Prior Year to All-Time High of $24.1 Million

BDSI : 4.80 (+1.05%)
BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced its plans to report its second-quarter...

BDSI : 4.80 (+1.05%)
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of...

BDSI : 4.80 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BDSI with:

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

2nd Resistance Point 4.89
1st Resistance Point 4.84
Last Price 4.80
1st Support Level 4.73
2nd Support Level 4.67

See More

52-Week High 5.37
Last Price 4.80
Fibonacci 61.8% 4.39
Fibonacci 50% 4.09
Fibonacci 38.2% 3.78
52-Week Low 2.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar